Literature DB >> 22482774

Potential and limitations of ensemble docking.

Oliver Korb1, Tjelvar S G Olsson, Simon J Bowden, Richard J Hall, Marcel L Verdonk, John W Liebeschuetz, Jason C Cole.   

Abstract

A major problem in structure-based virtual screening applications is the appropriate selection of a single or even multiple protein structures to be used in the virtual screening process. A priori it is unknown which protein structure(s) will perform best in a virtual screening experiment. We investigated the performance of ensemble docking, as a function of ensemble size, for eight targets of pharmaceutical interest. Starting from single protein structure docking results, for each ensemble size up to 500,000 combinations of protein structures were generated, and, for each ensemble, pose prediction and virtual screening results were derived. Comparison of single to multiple protein structure results suggests improvements when looking at the performance of the worst and the average over all single protein structures to the performance of the worst and average over all protein ensembles of size two or greater, respectively. We identified several key factors affecting ensemble docking performance, including the sampling accuracy of the docking algorithm, the choice of the scoring function, and the similarity of database ligands to the cocrystallized ligands of ligand-bound protein structures in an ensemble. Due to these factors, the prospective selection of optimum ensembles is a challenging task, shown by a reassessment of published ensemble selection protocols.

Mesh:

Substances:

Year:  2012        PMID: 22482774     DOI: 10.1021/ci2005934

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  47 in total

Review 1.  Receptor-ligand molecular docking.

Authors:  Isabella A Guedes; Camila S de Magalhães; Laurent E Dardenne
Journal:  Biophys Rev       Date:  2013-12-21

Review 2.  Microscopic Characterization of Membrane Transporter Function by In Silico Modeling and Simulation.

Authors:  J V Vermaas; N Trebesch; C G Mayne; S Thangapandian; M Shekhar; P Mahinthichaichan; J L Baylon; T Jiang; Y Wang; M P Muller; E Shinn; Z Zhao; P-C Wen; E Tajkhorshid
Journal:  Methods Enzymol       Date:  2016-07-11       Impact factor: 1.600

Review 3.  Principles and Overview of Sampling Methods for Modeling Macromolecular Structure and Dynamics.

Authors:  Tatiana Maximova; Ryan Moffatt; Buyong Ma; Ruth Nussinov; Amarda Shehu
Journal:  PLoS Comput Biol       Date:  2016-04-28       Impact factor: 4.475

4.  Computing Ligands Bound to Proteins Using MELD-Accelerated MD.

Authors:  Cong Liu; Emiliano Brini; Alberto Perez; Ken A Dill
Journal:  J Chem Theory Comput       Date:  2020-09-23       Impact factor: 6.006

Review 5.  Induced fit docking, and the use of QM/MM methods in docking.

Authors:  Mengang Xu; Markus A Lill
Journal:  Drug Discov Today Technol       Date:  2013-09

6.  Using machine learning to improve ensemble docking for drug discovery.

Authors:  Tanay Chandak; John P Mayginnes; Howard Mayes; Chung F Wong
Journal:  Proteins       Date:  2020-05-25

7.  BP-Dock: a flexible docking scheme for exploring protein-ligand interactions based on unbound structures.

Authors:  Ashini Bolia; Z Nevin Gerek; S Banu Ozkan
Journal:  J Chem Inf Model       Date:  2014-03-04       Impact factor: 4.956

8.  The Development of Target-Specific Pose Filter Ensembles To Boost Ligand Enrichment for Structure-Based Virtual Screening.

Authors:  Jie Xia; Jui-Hua Hsieh; Huabin Hu; Song Wu; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2017-06-01       Impact factor: 4.956

9.  Enhancing Virtual Screening Performance of Protein Kinases with Molecular Dynamics Simulations.

Authors:  Tavina L Offutt; Robert V Swift; Rommie E Amaro
Journal:  J Chem Inf Model       Date:  2016-10-03       Impact factor: 4.956

10.  Structure-based predictions of activity cliffs.

Authors:  Jarmila Husby; Giovanni Bottegoni; Irina Kufareva; Ruben Abagyan; Andrea Cavalli
Journal:  J Chem Inf Model       Date:  2015-05-11       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.